Savara Inc(SVRA)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

SVRA Savara Inc

已收盘 12-11 16:00:00 EST

6.94

+0.25

+3.74%

盘后7.05

+0.11+1.59%

19:59 EST

最高7.00	最低6.65	成交量297.11万
今开6.69	昨收6.69	日振幅5.23%
总市值14.12亿	流通市值7.98亿	总股本2.03亿
成交额2,049万	换手率2.58%	流通股本1.15亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"SVRA","market":"US","secType":"STK","nameCN":"Savara Inc","latestPrice":6.94,"timestamp":1765486800000,"preClose":6.69,"halted":0,"volume":2971108,"hourTrading":{"tag":"盘后","latestPrice":7.05,"preClose":6.94,"latestTime":"19:59 EST","volume":127396,"amount":884302.8346,"timestamp":1765501185595},"delay":0,"floatShares":114999999,"shares":203467845,"eps":-0.535012,"marketStatus":"已收盘","change":0.25,"latestTime":"12-11 16:00:00 EST","open":6.69,"high":7,"low":6.65,"amount":20486782.010072,"amplitude":0.052317,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.535012,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1765530000000},"marketStatusCode":5,"adr":0,"adrRate":0,"exchange":"NASDAQ","adjPreClose":6.69,"preHourTrading":{"tag":"盘前","latestPrice":6.8,"preClose":6.69,"latestTime":"09:00 EST","volume":4799,"amount":32626.200658499998,"timestamp":1765461609802},"postHourTrading":{"tag":"盘后","latestPrice":7.05,"preClose":6.94,"latestTime":"19:59 EST","volume":127396,"amount":884302.8346,"timestamp":1765501185595},"volumeRatio":0.783859,"impliedVol":0.9867,"impliedVolPercentile":0.576},"requestUrl":"/m/hq/s/SVRA/wiki","defaultTab":"wiki","newsList":[{"id":"1104472090","title":"Savara宣布欧洲专利局计划授予Molbreevi液体制剂专利","url":"https://stock-news.laohu8.com/highlight/detail?id=1104472090","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1104472090?lang=zh_cn&edition=full","pubTime":"2025-12-11 21:06","pubTimestamp":1765458399,"startTime":"0","endTime":"0","summary":"Savara宣布欧洲专利局计划授予Molbreevi液体制剂专利","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","SVRA"],"gpt_icon":0},{"id":"1192654143","title":"Master Tec任命钟鹏康为首席财务官","url":"https://stock-news.laohu8.com/highlight/detail?id=1192654143","media":"投资观察","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1192654143?lang=zh_cn&edition=full","pubTime":"2025-11-21 19:14","pubTimestamp":1763723672,"startTime":"0","endTime":"0","summary":"11月21日 - Master Tec Group Bhd宣布任命钟鹏康为首席财务官。有关公司的更多信息请见MAST.KL。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","SVRA"],"gpt_icon":0},{"id":"1102629162","title":"万事达科技集团季度净利润达860万令吉","url":"https://stock-news.laohu8.com/highlight/detail?id=1102629162","media":"投资观察","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1102629162?lang=zh_cn&edition=full","pubTime":"2025-11-21 18:46","pubTimestamp":1763721993,"startTime":"0","endTime":"0","summary":"11月21日 - 万事达科技集团Bhd报告称：季度净利润为860万令吉，季度收入为1.158亿令吉。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","SVRA"],"gpt_icon":0},{"id":"1152895044","title":"Savara第三季度净收入为负2956.1万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1152895044","media":"投资观察","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1152895044?lang=zh_cn&edition=full","pubTime":"2025-11-20 01:33","pubTimestamp":1763573620,"startTime":"0","endTime":"0","summary":"11月12日 - Savara第三季度营业收入为负3025.5万美元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","SVRA"],"gpt_icon":0},{"id":"1133223112","title":"Mastek任命Deepak Kedia为首席财务官","url":"https://stock-news.laohu8.com/highlight/detail?id=1133223112","media":"投资观察","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1133223112?lang=zh_cn&edition=full","pubTime":"2025-11-11 22:31","pubTimestamp":1762871515,"startTime":"0","endTime":"0","summary":"11月11日 - Mastek Ltd宣布任命Deepak Kedia为首席财务官。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SVRA","BK4139"],"gpt_icon":0},{"id":"1126678734","title":"Savara与Rtw达成7500万美元的特许权资助协议以支持Molbreevi*在自身免疫性肺泡蛋白沉积症中的潜在上市","url":"https://stock-news.laohu8.com/highlight/detail?id=1126678734","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1126678734?lang=zh_cn&edition=full","pubTime":"2025-10-30 04:02","pubTimestamp":1761768133,"startTime":"0","endTime":"0","summary":"Savara与Rtw达成7500万美元的特许权资助协议，以支持Molbreevi*在自身免疫性肺泡蛋白沉积症（Autoimmune Pap）中的潜在上市。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SVRA","BK4139"],"gpt_icon":0},{"id":"2577453148","title":"Savara, Inc.盘中异动 股价大涨5.23%报4.33美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2577453148","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2577453148?lang=zh_cn&edition=full","pubTime":"2025-10-23 21:34","pubTimestamp":1761226483,"startTime":"0","endTime":"0","summary":"北京时间2025年10月23日21时34分，Savara, Inc.股票出现异动，股价快速上涨5.23%。截至发稿，该股报4.33美元/股，成交量6.7028万股，换手率0.04%，振幅4.86%。Savara, Inc.股票所在的生物技术行业中，整体跌幅为0.08%。其相关个股中，Ventyx Biosciences, Inc.、Ibio, Inc.、Moleculin Biotech, Inc.涨幅较大，Nls Pharmaceutics Ltd.、Ventyx Biosciences, Inc.、Ibio, Inc.较为活跃，换手率分别为147.52%、77.55%、62.61%，振幅较大的相关个股有Ethzilla Corporation C/Wts 06/11/2025、Tango Therapeutics, Inc.、Ventyx Biosciences, Inc.，振幅分别为22.45%、20.67%、18.13%。Savara, Inc.公司简介：Savara Inc 是一家生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251023213443a470c52f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251023213443a470c52f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["VTYX","BK4139","SVRA","BK4007"],"gpt_icon":0},{"id":"1129154696","title":"Mastek Ltd 九月季度合并净利润为974.5百万卢比","url":"https://stock-news.laohu8.com/highlight/detail?id=1129154696","media":"投资观察","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1129154696?lang=zh_cn&edition=full","pubTime":"2025-10-16 15:56","pubTimestamp":1760601401,"startTime":"0","endTime":"0","summary":"10月16日 - Mastek Ltd公布：*九月季度合并净利润为974.5百万卢比*；九月季度合并营收为94亿卢比。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","SVRA"],"gpt_icon":0},{"id":"1161322994","title":"Savara Inc宣布将在Chest 2025大会上再次展示莫拉司汀吸入溶液治疗自身免疫性肺泡蛋白沉积症的三期Impala-2临床试验结果","url":"https://stock-news.laohu8.com/highlight/detail?id=1161322994","media":"美股速递","labels":["conferences","dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1161322994?lang=zh_cn&edition=full","pubTime":"2025-10-03 04:06","pubTimestamp":1759435614,"startTime":"0","endTime":"0","summary":"Savara Inc宣布将在Chest 2025大会上再次展示莫拉司汀吸入溶液(Molgramostim)治疗自身免疫性肺泡蛋白沉积症(APAP)患者的三期Impala-2临床试验结果。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"conferences,dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SVRA","BK4139"],"gpt_icon":0},{"id":"1122657632","title":"Savara Inc在2025年欧洲呼吸学会大会上发布Molgramostim吸入溶液治疗自身免疫性肺泡蛋白沉着症患者的3期IMPALA-2临床试验最新数据","url":"https://stock-news.laohu8.com/highlight/detail?id=1122657632","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1122657632?lang=zh_cn&edition=full","pubTime":"2025-09-29 14:00","pubTimestamp":1759125629,"startTime":"0","endTime":"0","summary":"Savara Inc在2025年欧洲呼吸学会大会上发布Molgramostim吸入溶液治疗自身免疫性肺泡蛋白沉着症患者的3期IMPALA-2临床试验最新数据","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","SVRA"],"gpt_icon":0},{"id":"2557598380","title":"Savara, Inc.盘中异动 下午盘快速下挫5.29%报2.60美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2557598380","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2557598380?lang=zh_cn&edition=full","pubTime":"2025-08-08 01:15","pubTimestamp":1754586921,"startTime":"0","endTime":"0","summary":"北京时间2025年08月08日01时15分，Savara, Inc.股票出现波动，股价快速跳水5.29%。截至发稿，该股报2.60美元/股，成交量20.8437万股，换手率0.12%，振幅5.84%。Savara, Inc.股票所在的生物技术行业中，整体跌幅为0.27%。其相关个股中，60 Degrees Pharmaceuticals Inc C/Wts 12/07/2028 、Cingulate Inc C/Wts 10/12/2026 、C4 Therapeutics, Inc.涨幅较大，Palisade Bio, Inc.、Bioxcel Therapeutics, Inc.、Tnf Pharmaceuticals, Inc.较为活跃，换手率分别为1783.81%、207.31%、94.95%，振幅较大的相关个股有Palisade Bio, Inc.、60 Degrees Pharmaceuticals Inc C/Wts 12/07/2028 、Omniab Inc C/Wts ，振幅分别为94.71%、82.50%、55.56%。Savara, Inc.公司简介：Savara Inc 是一家生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025080801152294d5f462&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025080801152294d5f462&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SVRA","BK4139"],"gpt_icon":0},{"id":"2557387319","title":"Savara, Inc.盘中异动 临近收盘急速上涨5.25%报2.71美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2557387319","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2557387319?lang=zh_cn&edition=full","pubTime":"2025-08-06 03:33","pubTimestamp":1754422436,"startTime":"0","endTime":"0","summary":"北京时间2025年08月06日03时33分，Savara, Inc.股票出现异动，股价快速上涨5.25%。截至发稿，该股报2.71美元/股，成交量44.9328万股，换手率0.26%，振幅6.81%。Savara, Inc.股票所在的生物技术行业中，整体跌幅为3.64%。其相关个股中，Y-Mabs Therapeutics, Inc.、60 Degrees Pharmaceuticals Inc C/Wts 12/07/2028 、Conduit Pharmaceuticals Inc C/Wts 22/09/2028涨幅较大，Bioxcel Therapeutics, Inc.、Shattuck Labs, Inc.、Psyence Biomedical Ltd.较为活跃，换手率分别为635.53%、192.26%、181.64%，振幅较大的相关个股有Conduit Pharmaceuticals Inc C/Wts 22/09/2028、60 Degrees Pharmaceuticals Inc C/Wts 12/07/2028 、Bioxcel Therapeutics, Inc.，振幅分别为67.96%、66.93%、48.03%。Savara, Inc.公司简介：Savara Inc 是一家生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250806033357a6d4ff67&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250806033357a6d4ff67&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","SVRA"],"gpt_icon":0},{"id":"2554770568","title":"Savara, Inc.盘中异动 早盘股价大涨5.23%","url":"https://stock-news.laohu8.com/highlight/detail?id=2554770568","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2554770568?lang=zh_cn&edition=full","pubTime":"2025-07-28 22:27","pubTimestamp":1753712824,"startTime":"0","endTime":"0","summary":"北京时间2025年07月28日22时27分，Savara, Inc.股票出现异动，股价急速上涨5.23%。截至发稿，该股报2.72美元/股，成交量143.788万股，换手率0.83%，振幅7.17%。Savara, Inc.股票所在的生物技术行业中，整体涨幅为0.30%。其相关个股中，Celcuity Inc.、Aim Immunotech Inc.、Lixte Biotechnology Holdings  Inc C/Wts 30/11/2025 涨幅较大，Aim Immunotech Inc.、Tnf Pharmaceuticals, Inc.、Cervomed Inc.较为活跃，换手率分别为339.29%、172.93%、111.93%，振幅较大的相关个股有Aim Immunotech Inc.、Celcuity Inc.、Rocket Pharmaceuticals Inc C/Wts 02/09/2026 ，振幅分别为106.96%、75.82%、71.61%。Savara, Inc.公司简介：Savara Inc 是一家生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250728222705a467ece4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250728222705a467ece4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SVRA","BK4139"],"gpt_icon":0},{"id":"2551138310","title":"Savara, Inc.盘中异动 急速拉升5.02%","url":"https://stock-news.laohu8.com/highlight/detail?id=2551138310","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2551138310?lang=zh_cn&edition=full","pubTime":"2025-07-15 00:52","pubTimestamp":1752511954,"startTime":"0","endTime":"0","summary":"北京时间2025年07月15日00时52分，Savara, Inc.股票出现异动，股价急速上涨5.02%。截至发稿，该股报2.51美元/股，成交量37.0817万股，换手率0.21%，振幅5.23%。Savara, Inc.股票所在的生物技术行业中，整体涨幅为0.72%。其相关个股中，Sonnet Biotherapeutics Holdings, Inc.、Dare Bioscience, Inc.、Promis Neurosciences Inc.涨幅较大，Windtree Therapeutics, Inc.、Sonnet Biotherapeutics Holdings, Inc.、Dare Bioscience, Inc.较为活跃，换手率分别为2067.32%、1198.84%、709.70%，振幅较大的相关个股有Promis Neurosciences Inc.、Dare Bioscience, Inc.、Sonnet Biotherapeutics Holdings, Inc.，振幅分别为210.04%、206.36%、199.81%。Savara, Inc.公司简介：Savara Inc 是一家生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250715005234a6a93adf&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250715005234a6a93adf&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","SVRA"],"gpt_icon":0},{"id":"2550954235","title":"Savara, Inc.盘中异动 股价大涨5.22%报2.42美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2550954235","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2550954235?lang=zh_cn&edition=full","pubTime":"2025-07-11 22:31","pubTimestamp":1752244290,"startTime":"0","endTime":"0","summary":"北京时间2025年07月11日22时31分，Savara, Inc.股票出现波动，股价急速上涨5.22%。截至发稿，该股报2.42美元/股，成交量14.8592万股，换手率0.09%，振幅7.39%。Savara, Inc.股票所在的生物技术行业中，整体跌幅为0.62%。其相关个股中，Mink Therapeutics, Inc.、Alterity Therapeutics Limited、Revelation Biosciences Inc C/Wts 10/01/2027 涨幅较大，Mink Therapeutics, Inc.、Cel-Sci Corporation、Dare Bioscience, Inc.较为活跃，换手率分别为417.90%、193.29%、81.69%，振幅较大的相关个股有Mink Therapeutics, Inc.、Cel-Sci Corporation、Lixte Biotechnology Holdings  Inc C/Wts 30/11/2025 ，振幅分别为450.19%、74.61%、35.73%。Savara, Inc.公司简介：Savara Inc 是一家生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250711223130a6a412ca&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250711223130a6a412ca&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SVRA","BK4139"],"gpt_icon":0},{"id":"2550656576","title":"Savara, Inc.盘中异动 股价大涨5.07%报2.39美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2550656576","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2550656576?lang=zh_cn&edition=full","pubTime":"2025-07-09 22:37","pubTimestamp":1752071864,"startTime":"0","endTime":"0","summary":"北京时间2025年07月09日22时37分，Savara, Inc.股票出现波动，股价大幅拉升5.07%。截至发稿，该股报2.39美元/股，成交量13.294万股，换手率0.08%，振幅5.73%。Savara, Inc.股票所在的生物技术行业中，整体涨幅为1.23%。其相关个股中，Calidi Biotherapeutics, Inc.、60 Degrees Pharmaceuticals Inc C/Wts 12/07/2028 、Lixte Biotechnology Holdings  Inc C/Wts 30/11/2025 涨幅较大，Calidi Biotherapeutics, Inc.、Kazia Therapeutics Limited、Mustang Bio, Inc.较为活跃，换手率分别为1059.74%、702.87%、520.23%，振幅较大的相关个股有Calidi Biotherapeutics, Inc.、Lixte Biotechnology Holdings  Inc C/Wts 30/11/2025 、Prokidney Corp.，振幅分别为173.13%、112.02%、48.79%。Savara, Inc.公司简介：Savara Inc 是一家生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250709223745a69fa6d3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250709223745a69fa6d3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SVRA","BK4139"],"gpt_icon":0},{"id":"2549298559","title":"Savara, Inc.盘中异动 临近午盘股价大涨5.25%报2.31美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2549298559","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2549298559?lang=zh_cn&edition=full","pubTime":"2025-07-07 23:47","pubTimestamp":1751903239,"startTime":"0","endTime":"0","summary":"北京时间2025年07月07日23时47分，Savara, Inc.股票出现异动，股价快速上涨5.25%。截至发稿，该股报2.31美元/股，成交量58.0079万股，换手率0.34%，振幅6.85%。Savara, Inc.股票所在的生物技术行业中，整体涨幅为0.03%。其相关个股中，Mustang Bio, Inc.、Pelthos Therapeutics Inc.、Artelo Biosciences, Inc.涨幅较大，Mustang Bio, Inc.、Artelo Biosciences, Inc.、Sonnet Biotherapeutics Holdings, Inc.较为活跃，换手率分别为5246.48%、1178.69%、861.63%，振幅较大的相关个股有Mustang Bio, Inc.、Pelthos Therapeutics Inc.、Artelo Biosciences, Inc.，振幅分别为298.32%、187.40%、84.08%。Savara, Inc.公司简介：Savara Inc 是一家生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250707234719a69b47ae&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250707234719a69b47ae&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","SVRA"],"gpt_icon":0},{"id":"2548020820","title":"Savara, Inc.盘中异动 早盘快速跳水5.48%报2.16美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2548020820","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2548020820?lang=zh_cn&edition=full","pubTime":"2025-07-01 21:50","pubTimestamp":1751377845,"startTime":"0","endTime":"0","summary":"北京时间2025年07月01日21时50分，Savara, Inc.股票出现异动，股价大幅跳水5.48%。截至发稿，该股报2.16美元/股，成交量39.3189万股，换手率0.23%，振幅4.82%。Savara, Inc.股票所在的生物技术行业中，整体跌幅为0.15%。其相关个股中，Lixte Biotechnology Holdings, Inc.、Atai Life Sciences N.V.、Neurogene Inc.涨幅较大，Oragenics Inc.、Soligenix, Inc.、Lixte Biotechnology Holdings, Inc.较为活跃，换手率分别为1642.24%、1083.33%、71.66%，振幅较大的相关个股有Lixte Biotechnology Holdings, Inc.、Unity Biotechnology, Inc.、Neurogene Inc.，振幅分别为56.35%、27.62%、21.87%。Savara, Inc.公司简介：Savara Inc 是一家生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202507012150469795fa26&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202507012150469795fa26&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SVRA","BK4139"],"gpt_icon":0},{"id":"2546430122","title":"Savara, Inc.盘中异动 早盘股价大跌5.26%报2.16美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2546430122","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2546430122?lang=zh_cn&edition=full","pubTime":"2025-06-25 21:31","pubTimestamp":1750858298,"startTime":"0","endTime":"0","summary":"北京时间2025年06月25日21时31分，Savara, Inc.股票出现异动，股价急速下挫5.26%。截至发稿，该股报2.16美元/股，成交量1.0925万股，换手率0.01%，振幅1.75%。Savara, Inc.股票所在的生物技术行业中，整体跌幅为0.29%。其相关个股中，Plus Therapeutics, Inc.、Nutriband Inc C/Wts 、Geovax Labs Inc C/Wts 29/09/2025涨幅较大，Plus Therapeutics, Inc.、Zyversa Therapeutics, Inc.、Portage Biotech Inc.较为活跃，换手率分别为598.22%、197.42%、140.63%，振幅较大的相关个股有Plus Therapeutics, Inc.、Impact Biomedical, Inc.、180 Life Sciences Corp.，振幅分别为29.41%、13.15%、11.45%。Savara, Inc.公司简介：Savara Inc 是一家生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250625213138978e802a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250625213138978e802a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SVRA","BK4139"],"gpt_icon":0},{"id":"2544699245","title":"Savara, Inc.盘中异动 股价大跌5.05%报2.07美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2544699245","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2544699245?lang=zh_cn&edition=full","pubTime":"2025-06-18 01:32","pubTimestamp":1750181560,"startTime":"0","endTime":"0","summary":"北京时间2025年06月18日01时32分，Savara, Inc.股票出现波动，股价急速下挫5.05%。截至发稿，该股报2.07美元/股，成交量25.731万股，换手率0.15%，振幅4.59%。Savara, Inc.股票所在的生物技术行业中，整体跌幅为1.05%。其相关个股中，Cero Therapeutics Holdings Inc C/Wts 13/02/2029 、Cero Therapeutics Holdings, Inc.、Acurx Pharmaceuticals, Inc.涨幅较大，Cero Therapeutics Holdings, Inc.、Processa Pharmaceuticals, Inc.、Salarius Pharmaceuticals, Inc.较为活跃，换手率分别为9543.97%、4552.24%、2352.99%，振幅较大的相关个股有Cero Therapeutics Holdings Inc C/Wts 13/02/2029 、Processa Pharmaceuticals, Inc.、Cero Therapeutics Holdings, Inc.，振幅分别为450.48%、260.06%、242.28%。Savara, Inc.公司简介：Savara Inc 是一家生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202506180132409783b1b7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202506180132409783b1b7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","SVRA"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.savarapharma.com;www.masttherapeutics.com","stockEarnings":[{"period":"1week","weight":0.0619},{"period":"1month","weight":0.6725},{"period":"3month","weight":0.8635},{"period":"6month","weight":2.0271},{"period":"1year","weight":0.9911},{"period":"ytd","weight":1.1792}],"compareEarnings":[{"period":"1week","weight":0.0054},{"period":"1month","weight":0.009},{"period":"3month","weight":0.0455},{"period":"6month","weight":0.1517},{"period":"1year","weight":0.1406},{"period":"ytd","weight":0.1732}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Savara Inc.作为一家特拉华州公司，是一家生物制药公司，致力于开发用于治疗严重或危及生命的疾病。公司一直致力于其绝大部分资源去研究和开发（“R&D”），并收购其候选产品。公司尚未上市或尚未销售任何产品或产生任何显著的收入。2011年通过公司收购SynthRx有限公司，公司收购了该公司的膜粘附和密封胶技术平台，其中包括专有的泊洛沙姆相关的数据和发展了二十多年的临床，非临床和制造经验的知识，公司正在利用马斯特平台开发的MST -188去治疗疾病，其特点是微循环供血不足的条件。在以往年度，公司正在开发Exelbine和ANX- 514，这两者都是研究性肿瘤的程序，但在2012年伊始，公司已经把公司的资源几乎完全集中在MST- 188的开发。 公司于1995年12月在特拉华州成立。","yearOnYearQuotes":[{"month":1,"riseRate":0.5,"avgChangeRate":0.121255},{"month":2,"riseRate":0.25,"avgChangeRate":-0.051283},{"month":3,"riseRate":0.416667,"avgChangeRate":-0.01131},{"month":4,"riseRate":0.615385,"avgChangeRate":0.035184},{"month":5,"riseRate":0.692308,"avgChangeRate":0.023552},{"month":6,"riseRate":0.461538,"avgChangeRate":-0.033774},{"month":7,"riseRate":0.461538,"avgChangeRate":-0.023739},{"month":8,"riseRate":0.538462,"avgChangeRate":0.016257},{"month":9,"riseRate":0.538462,"avgChangeRate":0.011115},{"month":10,"riseRate":0.153846,"avgChangeRate":-0.136764},{"month":11,"riseRate":0.538462,"avgChangeRate":0.131385},{"month":12,"riseRate":0.615385,"avgChangeRate":0.227902}],"exchange":"NASDAQ","name":"Savara Inc","nameEN":"Savara Inc"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.35.11","shortVersion":"4.35.11","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Savara Inc(SVRA)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Savara Inc(SVRA)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Savara Inc,SVRA,Savara Inc股票,Savara Inc股票老虎,Savara Inc股票老虎国际,Savara Inc行情,Savara Inc股票行情,Savara Inc股价,Savara Inc股市,Savara Inc股票价格,Savara Inc股票交易,Savara Inc股票购买,Savara Inc股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Savara Inc(SVRA)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Savara Inc(SVRA)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}